View in EDS

Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.
Authors: van Wilpe S; Medical Oncology Department, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands. Electronic address: sandra.vanwilpe@radboudumc.nl., Taha T; Institute of Cancer Research and Royal Marsden Hospital, London, UK., Rothmann EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Altshuler E; Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins, Baltimore, MD, USA., Park J; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA., Ledet EM; Tulane Cancer Centre, Tulane University, New Orleans, LA, USA., Rothermundt C; Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Willemsen AECAB; Department of Internal Medicine, Tergooi Medical Centre, Hilversum, The Netherlands., Tsantoulis P; Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Oldenburg J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Bernard-Tessier A; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Robbrecht DGJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bruijnen CP; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Antonarakis ES; Masonic Cancer Centre, University of Minnesota, Minneapolis, MN, USA., Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA., Sartor O; Tulane Cancer Centre, Tulane University, New Orleans, LA, USA., Sena LA; Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins, Baltimore, MD, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., de Bono JS; Institute of Cancer Research and Royal Marsden Hospital, London, UK., Mehra N; Medical Oncology Department, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.
Source: European urology oncology [Eur Urol Oncol] 2025 Aug; Vol. 8 (4), pp. 1020-1029. Date of Electronic Publication: 2025 Jul 12.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40651931
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Wilpe+S%22">van Wilpe S</searchLink>; Medical Oncology Department, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands. Electronic address: sandra.vanwilpe@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22Taha+T%22">Taha T</searchLink>; Institute of Cancer Research and Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Rothmann+EC%22">Rothmann EC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Altshuler+E%22">Altshuler E</searchLink>; Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ledet+EM%22">Ledet EM</searchLink>; Tulane Cancer Centre, Tulane University, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Rothermundt+C%22">Rothermundt C</searchLink>; Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bergman+AM%22">Bergman AM</searchLink>; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Willemsen+AECAB%22">Willemsen AECAB</searchLink>; Department of Internal Medicine, Tergooi Medical Centre, Hilversum, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tsantoulis+P%22">Tsantoulis P</searchLink>; Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oldenburg+J%22">Oldenburg J</searchLink>; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Bernard-Tessier+A%22">Bernard-Tessier A</searchLink>; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Fizazi+K%22">Fizazi K</searchLink>; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Robbrecht+DGJ%22">Robbrecht DGJ</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bruijnen+CP%22">Bruijnen CP</searchLink>; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Hulle+T%22">van der Hulle T</searchLink>; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Antonarakis+ES%22">Antonarakis ES</searchLink>; Masonic Cancer Centre, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Omlin+A%22">Omlin A</searchLink>; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grönberg+H%22">Grönberg H</searchLink>; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Armstrong+AJ%22">Armstrong AJ</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sartor+O%22">Sartor O</searchLink>; Tulane Cancer Centre, Tulane University, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Sena+LA%22">Sena LA</searchLink>; Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22de+Bono+JS%22">de Bono JS</searchLink>; Institute of Cancer Research and Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Mehra+N%22">Mehra N</searchLink>; Medical Oncology Department, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2025 Aug; Vol. 8 (4), pp. 1020-1029. <i>Date of Electronic Publication: </i>2025 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40651931
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euo.2025.04.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1020
    Titles:
      – TitleFull: Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Wilpe S
      – PersonEntity:
          Name:
            NameFull: Taha T
      – PersonEntity:
          Name:
            NameFull: Rothmann EC
      – PersonEntity:
          Name:
            NameFull: Altshuler E
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Ledet EM
      – PersonEntity:
          Name:
            NameFull: Rothermundt C
      – PersonEntity:
          Name:
            NameFull: Bergman AM
      – PersonEntity:
          Name:
            NameFull: Willemsen AECAB
      – PersonEntity:
          Name:
            NameFull: Tsantoulis P
      – PersonEntity:
          Name:
            NameFull: Oldenburg J
      – PersonEntity:
          Name:
            NameFull: Bernard-Tessier A
      – PersonEntity:
          Name:
            NameFull: Fizazi K
      – PersonEntity:
          Name:
            NameFull: Robbrecht DGJ
      – PersonEntity:
          Name:
            NameFull: Bruijnen CP
      – PersonEntity:
          Name:
            NameFull: van der Hulle T
      – PersonEntity:
          Name:
            NameFull: Antonarakis ES
      – PersonEntity:
          Name:
            NameFull: Omlin A
      – PersonEntity:
          Name:
            NameFull: Grönberg H
      – PersonEntity:
          Name:
            NameFull: Armstrong AJ
      – PersonEntity:
          Name:
            NameFull: Sartor O
      – PersonEntity:
          Name:
            NameFull: Sena LA
      – PersonEntity:
          Name:
            NameFull: Beltran H
      – PersonEntity:
          Name:
            NameFull: de Bono JS
      – PersonEntity:
          Name:
            NameFull: Mehra N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2588-9311
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: European urology oncology
              Type: main
ResultId 1